»ó´Ü¿©¹é
±â»ç (Àüü 2,745°Ç)
[Sub Story] ¡°Ç÷´çÆò°¡¿¡ A1C À̾î CGM¡¤TIR È°¿ëÇÏ¶ó¡± ÀÌ»óµ· ±âÀÚ 2024-02-07 13:50
[Sub Story] ´ç´¢º´ ¿¹¹æ ¾à¹°Ä¡·á¿¡ ¸ÞÆ®Æ÷¸£¹Î À¯ÀÏ ±Ç°í ÀÌ»óµ· ±âÀÚ 2024-02-07 13:35
[Journal Briefing] ¾ÆÇÈ»ç¹Ý, ¾Æ½ºÇǸ°º¸´Ù ³úÁ¹Áß À§Çè ³·°í ÃâÇ÷À§Çè ³ô¾Æ Á¤¿¬ÁÖ ±âÀÚ 2024-02-07 13:27
[Journal Briefing] °í¿ë·® ¾Æ½ºÇǸ° Àú¿ë·® ´ëºñ ´ç´¢º´¡¤ASCVD ÇýÅà Â÷ÀÌ ¾ø¾î Á¤¿¬ÁÖ ±âÀÚ 2024-02-07 13:22
[Conference Report] SGLT-2i+TZD, Ç÷´çÁ¶Àý¿¡¼­ Ç¥ÀûÀå±â º¸È£È¿°ú±îÁö ½Ã³ÊÁö ±â´ë THE MOST 2024-02-07 13:19
¶óÀÎ
[Sub Story] 50¼¼ ÀÌ»ó °ñ°¨¼ÒÁõ À¯º´·ü 50%¿¡ À°¹Ú¡¦ºñ»óµî ±ô¹Ú ÀÌ»óµ· ±âÀÚ 2024-02-07 12:01
[Interview] ½ÉÇ÷°üÁúȯ 2Â÷¿¹¹æ¿¡ ȯÀÚº° ½ºÅ¸Æ¾ ¸ÂÃãÄ¡·á ±Ù°Å ¸¶·ÃµÅ ÀÌ»óµ· ±âÀÚ 2024-02-07 11:48
[Sub Story] ´ç´¢º´ ȯÀÚ LDL-C Á¶Àý¿¡µµ ½ºÅ¸Æ¾ ÀÌ»óµ· ±âÀÚ 2024-02-07 11:42
[Sub Story] ´ç´¢º´ Áø´ÜÁöÇ¥ A1C¿¡ ´õ ¹«°Ô ÀÌ»óµ· ±âÀÚ 2024-02-07 09:54
[Cover Story] ¼öøÀ¸·Î º¸´Â 2024 ADA °¡À̵å¶óÀÎ ÀÌ»óµ· ±âÀÚ 2024-02-07 09:49
¶óÀÎ
[Journal Briefing] Ŭ·ÎÇǵµ±×·¼, PCI ¹ÞÀº °íÀ§Çè ȯÀÚ¿¡¼­µµ ¿ì¼öÇÒ±î? Á¤¿¬ÁÖ ±âÀÚ 2024-01-23 16:46
[Journal Briefing] Ƽ¸£Á¦ÆÄŸÀ̵å, üÁß°¨¼Ò À¯Áö À§ÇØ Ä¡·á Áö¼ÓÇØ¾ß Á¤¿¬ÁÖ ±âÀÚ 2024-01-23 16:44
[Journal Briefing] GLP-1RA, Àν¶¸° ´ëºñ Ç÷´çÁ¶Àý¡¤Ã¼Áß°¨¼Ò È¿°ú¡è ÀúÇ÷´ç À§Çè¡é Á¤¿¬ÁÖ ±âÀÚ 2024-01-23 16:42
[Journal Briefing] ½ºÅ¸Æ¾ º´¿ë¿ä¹ý, °í°­µµ ´Üµ¶ ´ëºñ ºñ¿­µîÇØ Á¤¿¬ÁÖ ±âÀÚ 2024-01-15 16:28
[Journal Briefing] ½ºÅ¸Æ¾ º´¿ë°ú ´Üµ¶¿ä¹ý, ¸®¾ó¿ùµå °á°ú´Â? Á¤¿¬ÁÖ ±âÀÚ 2024-01-15 16:26
¶óÀÎ
[Conference Report] CCB À¯È¿¼º¡¤¾ÈÀü¼º ÇÑ°è º£´ÏµðÇÉÀ¸·Î ±Øº¹ÇÑ´Ù ÀÌ»óµ· ±âÀÚ 2024-01-15 13:47
[Interview] ½ÉÇ÷°üÁúȯ ¿¹¹æ ÀÓ»ó±Ù°Å °í°­µµ ½ºÅ¸Æ¾ µ¶º¸Àû ÀÌ»óµ· ±âÀÚ 2024-01-15 13:38
[Drug Review] IBS¡¤AAD¡¤¿ø³»°¨¿° ¼³»ç µî¿¡ ³ôÀº ÀÓ»ó±Ù°Å º¸À¯ ÀÌ»óµ· ±âÀÚ 2024-01-15 11:53
[Sub Story] ¼³»çÇü¡¤º¯ºñÇü¿¡ °¢°¢ ¾à¹°Ä¡·á ±Ç°í¾È Á¦½Ã ÀÌ»óµ· ±âÀÚ 2024-01-15 11:24
[Sub Story] À§¿°È¯ÀÚ À§¾Ï¿¹¹æ¿¡ Á¦±ÕÄ¡·á ±Ç°í ÀÌ»óµ· ±âÀÚ 2024-01-12 13:20
Back to Top